Together, we see a recurring pattern among patients using GLP-1 medications as they prepare for surgery: many attempt to protect their results by restricting food intake, when in reality, proper nourishment is one of the most powerful tools for healing and recovery
Appetite might decrease slightly, and you might feel fuller after smaller meals
This will force other GLP-1 originators, such as tirzepatide and mazdutide, to reevaluate their pricing and market entry strategies and compel pipeline developers to recalibrate their China launch plans accordingly
A patient on 15 mg weekly might step down to 10 mg, then 7.5 mg, then 5 mg, then 2.5 mg, each for four weeks before the next reduction
Indigenous Services Canada coverage varies by region and specific health transfer agreements
You can access that training here: FULL LAUNCH BUNDLE This guide gives you the clarity you need to start safely including how to safely use the meds, the clinical boundaries, and why this model is working so well